Last reviewed · How we verify
FGF-1 141
At a glance
| Generic name | FGF-1 141 |
|---|---|
| Sponsor | Phage Pharmaceuticals, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Fibroblast Growth Factor-1 (FGF-1) for the Treatment of Coronary Heart Disease (PHASE2)
- Safety Study of Topical Human FGF-1 for Wound Healing (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |